West Pharmaceutical Services Inc (WST)
351.50
-2.98
(-0.84%)
USD |
NYSE |
May 15, 15:12
West Pharmaceutical Services Cash from Financing (Quarterly): -271.00M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -271.00M |
| December 31, 2023 | -189.50M |
| September 30, 2023 | -22.30M |
| June 30, 2023 | -176.80M |
| March 31, 2023 | -71.00M |
| December 31, 2022 | -9.50M |
| September 30, 2022 | -75.20M |
| June 30, 2022 | -36.20M |
| March 31, 2022 | -172.70M |
| December 31, 2021 | -6.20M |
| September 30, 2021 | -5.80M |
| June 30, 2021 | 0.30M |
| March 31, 2021 | -156.40M |
| December 31, 2020 | -8.70M |
| September 30, 2020 | -7.20M |
| June 30, 2020 | -0.90M |
| March 31, 2020 | -120.30M |
| December 31, 2019 | 51.00M |
| September 30, 2019 | -0.40M |
| June 30, 2019 | 3.10M |
| March 31, 2019 | -90.50M |
| December 31, 2018 | -8.20M |
| September 30, 2018 | 10.10M |
| June 30, 2018 | -25.70M |
| March 31, 2018 | -56.90M |
| Date | Value |
|---|---|
| December 31, 2017 | -86.50M |
| September 30, 2017 | -3.00M |
| June 30, 2017 | 2.30M |
| March 31, 2017 | -21.80M |
| December 31, 2016 | -26.40M |
| September 30, 2016 | -15.00M |
| June 30, 2016 | -7.40M |
| March 31, 2016 | -65.10M |
| December 31, 2015 | -1.60M |
| September 30, 2015 | -30.40M |
| June 30, 2015 | -10.70M |
| March 31, 2015 | 1.20M |
| December 31, 2014 | -1.80M |
| September 30, 2014 | -10.00M |
| June 30, 2014 | -45.20M |
| March 31, 2014 | 26.20M |
| December 31, 2013 | -23.50M |
| September 30, 2013 | 3.10M |
| June 30, 2013 | -40.20M |
| March 31, 2013 | 55.50M |
| December 31, 2012 | -29.50M |
| September 30, 2012 | 7.70M |
| June 30, 2012 | -5.80M |
| March 31, 2012 | 24.20M |
| December 31, 2011 | -28.10M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-271.00M
Minimum
Mar 2024
51.00M
Maximum
Dec 2019
-63.78M
Average
-15.90M
Median
Cash from Financing (Quarterly) Benchmarks
| Becton Dickinson & Co | 1.705B |
| Intuitive Surgical Inc | -46.70M |
| Masimo Corp | -26.50M |
| Merit Medical Systems Inc | -18.00M |
| Insulet Corp | -14.10M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 118.20M |
| Cash from Investing (Quarterly) | -90.60M |
| Free Cash Flow | 386.10M |
| Free Cash Flow Per Share (Quarterly) | 0.3715 |
| Free Cash Flow to Equity (Quarterly) | 28.20M |
| Free Cash Flow to Firm (Quarterly) | 27.60M |
| Free Cash Flow Yield | 1.47% |